摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-iodo benzene diazonium chloride | 56410-50-5

中文名称
——
中文别名
——
英文名称
2-iodo benzene diazonium chloride
英文别名
o-iodobenzenediazonium chloride;2-iodobenzenediazonium;chloride
2-iodo benzene diazonium chloride化学式
CAS
56410-50-5
化学式
C6H4IN2*Cl
mdl
——
分子量
266.469
InChiKey
OLDRFKWGWSSLBJ-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.22
  • 重原子数:
    10.0
  • 可旋转键数:
    0.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    28.15
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    2-iodo benzene diazonium chloride氢氧化钾 作用下, 以 乙醇 为溶剂, 反应 10.5h, 生成 2-碘苯硫酚
    参考文献:
    名称:
    通过Pd(0)催化烯丙基(和炔丙基)邻碘苯硫醚的分子内环化反应制备苯并[b]噻吩。
    摘要:
    苯并[b]噻吩是通过分子内Pd(0)催化的烯丙基邻碘苯硫醚的Heck反应制备的。在氢化物供体的存在下,Pd(0)催化邻碘苯基炔丙基硫的分子内环化反应生成3-亚甲基-2,3-二氢苯并[b]噻吩,该苯并噻吩在烯型反应中与数个亲烯体反应。但是,烯丙基(和炔丙基)芳基硫醚与氯化钯(II)反应,得到聚合的[PdCl(SAr)] 2。
    DOI:
    10.1016/s0040-4020(01)80255-6
  • 作为产物:
    描述:
    2-碘苯胺 在 sodium nitrite 作用下, 以 盐酸 为溶剂, 反应 0.75h, 生成 2-iodo benzene diazonium chloride
    参考文献:
    名称:
    通过Pd(0)催化烯丙基(和炔丙基)邻碘苯硫醚的分子内环化反应制备苯并[b]噻吩。
    摘要:
    苯并[b]噻吩是通过分子内Pd(0)催化的烯丙基邻碘苯硫醚的Heck反应制备的。在氢化物供体的存在下,Pd(0)催化邻碘苯基炔丙基硫的分子内环化反应生成3-亚甲基-2,3-二氢苯并[b]噻吩,该苯并噻吩在烯型反应中与数个亲烯体反应。但是,烯丙基(和炔丙基)芳基硫醚与氯化钯(II)反应,得到聚合的[PdCl(SAr)] 2。
    DOI:
    10.1016/s0040-4020(01)80255-6
点击查看最新优质反应信息

文献信息

  • Nitrogen bridgehead compounds. Part 18. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. Part I
    作者:Istvan Hermecz、Tibor Breining、Zoltan Meszaros、Agnes Horvath、Lelle Vasvari-Debreczy、Franz Dessy、Christine DeVos、Ludovic Rodriquez
    DOI:10.1021/jm00352a008
    日期:1982.10
    A new type of antiallergic agent, 9-hydrazono-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-ones, was synthesized and evaluated for inhibitory effects in the rat reagenic passive cutaneous anaphylaxis (PCA) screen. Several racemic 6-methyl derivatives were found to be more potent than disodium chromoglycate intravenously and some were also active orally. Structure-activity relationships are discussed
    合成了一种新型的抗过敏药9-基-6,7,8,9-四氢-4H-吡啶并[1,2-a]嘧啶-4-酮,并评估了其对大鼠自发性被动皮肤的抑制作用。过敏反应(PCA)屏幕。已发现几种消旋的6-甲基衍生物在静脉内比色甘酸二更有效,有些还具有口服活性。讨论了构效关系。在具有6S和6R绝对构型的对映异构体之间的6-甲基系列中观察到高立体特异性,前者更具活性。化合物17,(+)-6(S)-甲基-9-(苯基)-4-氧代-4H-吡啶并[1,2-a]嘧啶-3-羧酸[Chinoin-1045; [UCB L140],ED50值为1.0 mumol / kg po,目前正在临床研究中。
  • Synthesis of novel 5-substituted phenyl-3-(p-isopropylphenyl)-1-phenylformazan and their biological activities
    作者:Ayşe ŞAHİN YAĞLIOĞLU、Hülya ŞENÖZ
    DOI:10.3906/kim-1612-42
    日期:——
    Novel 1-substituted 3-(p-isopropylphenyl)-5-phenylformazans (3a--g) were synthesized and characterized by elemental analysis, $^1}$H NMR, and FT-IR techniques and UV-visible spectroscopy. Antiproliferative activities of 3a--g against HeLa and C6 cells were determined using the BrdU cell proliferation ELISA assay. 5-Florouracil was used as the positive control. The effects of substituents (--H, --CH$_3}$, and --I) and their positions ($ortho$, $meta$, and $para$) on the antiproliferative activities were evaluated. The results of the assay indicate that I substituent exhibited higher activity against the cells at the $meta$ and $para$ positions than --CH$_3}$ and --H substituents. 3a--g exhibited both high antiproliferative activities against C6 cells and noncytotoxicity. 3a--g may be anticancer drug candidates.
    合成了新型1-取代的3-(对异丙基苯基)-5-苯基偶氮化合物(3a-g),并通过元素分析、$^1}$H NMR、FT-IR技术及紫外-可见光光谱进行了表征。使用BrdU细胞增殖ELISA测定了3a-g对HeLa和C6细胞的抗增殖活性。5-尿嘧啶被用作阳性对照。评估了取代基(--H、--CH$_3}$和--I)及其在($ortho$、$meta$和$para$)位置上对抗增殖活性的影响。实验结果表明,I取代基在$meta$和$para$位点对细胞表现出比--CH$_3}$和--H取代基更高的活性。3a-g对C6细胞表现出较高的抗增殖活性且无细胞毒性。3a-g可能是抗癌药物候选物。
  • On the equilibrium between molecular complexes and trigonal bipyramidal adducts of diaryl selenide dibromides in solution
    作者:War? Nakanishi、Satoko Hayashi
    DOI:10.1002/hc.1056
    日期:——
    both δ(Ci) in 5. The equilibrium between MC's and TB adducts is clearly shown in 4. The equilibrium constants K (K = [MC]/[TB]) are also calculated: they are ca. 0.20 for 2 and 3 and 0.16, 0.33, and 0.73 for 4i, 4a, and 4e, respectively. The contribution of MC is negligible in 1a, and the contribution of the TB adduct is negligible in 5. The results show that TB adducts become unstable relative to MCs
    已经设计了一种可视化 ArSeBr2Ar' 的分子复合物 (MC) 和三角双锥 (TB) 加合物之间的平衡的方法。TB 地层引起同碳 δ(Ci) 的大的下场位移,而上场位移是 MC 地层中 δ(Ci) 的特征。因此,如果制备了这样的 ArSeAr',当被添加到 ArSeAr' 溶液中时,平衡被清楚地证明,该 ArSeAr' 显示在一个 ipso 碳上的上场位移,而另一个则向下场。测量 4-YC6H4SePh (1a–1g)、2-YC6H4SePh (2d, 2e, 2h), 2-YC6H4SeC6H4Br-p (3d, 3e, 3h), 2-O2NC6H4SeC6H4Y-的卤素引起的化学位移 (Δδ) (4a, 4e, 4i), 和 2,4-(O2N)2C6H3SeC6H4Y-p (5a, 5e, 5i), 其中 Y = H (a), OMe (b), Me (c), Cl (d), Br
  • Theoretical studies of the tautomerism in 3-(2-R-Phenylhydrazono)-naphthalene- 1,2,4-triones: synthesis of copper(II) complexes and studies of antibacterial and antitumor activities
    作者:Acácio I. Francisco、Maria D. Vargas、Thaís P. Fragoso、J. Walkimar de M. Carneiro、Annelise Casellato、Fernando de C. da Silva、Vitor F. Ferreira、Jussara P. Barbosa、Claudia Pessoa、Letícia V. Costa-Lotufo、José D. B. Marinho Filho、Manoel O. de Moraes、Antonio S. Mangrich
    DOI:10.1590/s0103-50532010000700017
    日期:——
    DFT calculations using the B3LYP and PBE1PBE functionals with the standard 6-31G(d) and 6-311+G(2d,p) basis sets were carried out for the 3-(2-phenylhydrazone)-naphthalene-1,2,4-trione system in solution (dmso) and in the gas phase, and showed the keto-hydrazone forms (rotamers Ia and Ib) to be more stable than the enol-azo forms (rotamers IIa and IIb, by about 14 kcal mol(-1)) and III (by approximately 6 kcal mol(-1)), independently of the nature of the substituent in the phenylene ring. These results were confirmed by spectroscopic data on the derivatives HL1-HL13, obtained from 2-hydroxy-1,4-naphthoquinone and arylamines (R = 4-OMe, 4-N-2-C6H5, 4-Cl, 4-I, 3-I, 2-I, 4-COOH, 3-COOH, 4-CN, 3-CN, 4-NO2, 3-NO2, 2-NO2). The in vitro antitumor (against SF-295, HCT-8, MDAMB-435 and HL-60 cancer cell lines) and antibacterial activities (Bacillus cereus, Bacillus subtilis, Enterococcus faecalis, Staphylococcus aureus, Escherichia coli, Klebsiella pneumonia and Pseudomonas aeruginosa) of compounds HL1-HL13 and of their respective copper(II) complexes, [Cu(L1-13)(2)], were tested. In general, these compounds exhibited low antibacterial activity, except for HL5 (R = 3-I), more active than the control; however, the corresponding complex was inactive. In contrast, increased cytotoxicity was observed upon complexation. Complex [Cu(L13)(2)] (R = 3-NO2) presented moderate cytotoxicity against human leukemia (HL-60).
  • NEPLYUEV V. M.; XOJNA E. V.; PELKIS P. S., UKR. XIM. ZH. 1980, 46, HO 2, 185-189
    作者:NEPLYUEV V. M.、 XOJNA E. V.、 PELKIS P. S.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫